Children represent approximately 11% of the global TB burden. In recent years, it has become apparent that survivors of TB disease may have life-long consequences with multiple morbidities including respiratory, cardiac, mental, neurological, and other disabilities. Although this entity is now well recognised and defined, data on this entity in the paediatric age group is just emerging.  The patterns, presentation, severity, and outcomes associated with PTLD in children and adolescents depend on the timing of the lung insult, the developmental stage and maturity of the immune system, and the potential for lung recovery with lung function ‘catch-up’ over time.

Educational aims

• The evidence on the burden of PTLD and multimorbidity
• What patterns of respiratory involvement in PTLD
• Clinical trial evidence on host directed therapies for PTLD
• Research gaps for PTLD and multimorbidity in children

Topics:

• What is PTLD
• How to diagnose PTLD
• What at the patterns of PTLD in children
• What is the multimorbidity associated with TB
• Host directed therapies for PTLD
• What are the research gaps in PTLD diagnosis and treatment

Target audience:

• Paediatricians
• Paediatric pulmonologists
• Fellows
• Respiratory physicians
• Physical therapists
• Nurses

Learning outcomes

Following this webinar, participants will be able to know latest evidence in terms of the definition, spectrum of lung disease, treatments, and potential treatments in PTLD in children as well as research gaps from both high and low to middle income countries perpectives.

REGISTER HERE